Fusion Versus Cognitive MRI Targeted Prostatic Biopsy
Prostatic Cancer
About this trial
This is an interventional diagnostic trial for Prostatic Cancer focused on measuring fusion biopsy
Eligibility Criteria
Inclusion Criteria: prostate biopsy-naïve men PSA levels of up to 20 ng/mL Multi-parametric prostate MRI revealed a PIRAD 4 or PIRAD 5. Exclusion Criteria: PSA level greater than 20 ng/mL patient with history of TRUS biopsy patient diagnosed as cancer prostate or with distant metastasis
Sites / Locations
- Menoufia University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
fusion biopsy
cognitive biopsy
This biopsy procedure that combines the pictures from an MRI and an ultrasound to create a detailed 3-D image of the prostate. This procedure makes it easier to see an abnormal area of prostate in order to guide the biopsy needle into the abnormal area. A sample of tissue can then be taken and checked under a microscope for cancer. A fusion biopsy may help find prostate cancer cells that may be missed with other types of biopsies. It may help find cancer at an early stage and plan cancer treatment.
the biopsy operator reviews the MR images and creates a mental three-dimensional representation of the prostate and of the lesion within it to take a biopsy from it